Literature DB >> 19870457

PATHOLOGY OF PNEUMOCOCCUS INFECTION IN MICE FOLLOWING INTRANASAL INSTILLATION.

G Rake1.   

Abstract

Pneumonia can be produced in mice, which have not been previously prepared, by intranasal inoculation of broth cultures of certain strains of pneumococci. Lesions which are quantitatively different can be produced in different breeds of mice by inoculation of the same type of pneumococcus. Similar inoculation of different types of pneumococci into one breed of mice results in lesions which are qualitatively different. In general, these lesions are as follows: a diffuse pneumonia and an acute glomerular nephritis in unselected mice receiving Type I strains; a confluent pneumonia and a tubular nephritis in the case of Type II strains; and as result of Type III strains, an interstitial pneumonia with extensive gelatinous pleurisy, together with necrosis and abscess formation in the spleen and cervical lymph nodes. Resistant strains of mice with Type III pneumococci show slight changes in the lungs, but marked lesions in the spleen and cervical nodes, while susceptible mice with the same type of pneumococcus show marked changes in the lung and moderate lesions in the spleen and cervical nodes. The method of development of Type III pneumonia, studied by means of serial sections of nasally infected mice, appears to proceed in the stages of vascular engorgement, interalveolar interstitial exudate, albuminous fluid exudate into the alveoli and the perivascular lymphatics draining the affected site, and finally, a frank pneumonia with a cellular exudate in the alveoli but without much fibrin.

Entities:  

Year:  1936        PMID: 19870457      PMCID: PMC2133315          DOI: 10.1084/jem.63.1.17

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  5 in total

1.  STUDIES ON EXPERIMENTAL PNEUMONIA : II. PATHOLOGY AND PATHOGENESIS OF PNEUMOCOCCUS LOBAR PNEUMONIA IN MONKEYS.

Authors:  F G Blake; R L Cecil
Journal:  J Exp Med       Date:  1920-03-31       Impact factor: 14.307

2.  INTRANASAL VIRULENCE OF PNEUMOCOCCI FOR MICE.

Authors:  L T Webster; A D Clow
Journal:  J Exp Med       Date:  1933-09-30       Impact factor: 14.307

3.  INHERITED AND ACQUIRED FACTORS IN RESISTANCE TO INFECTION : II. A COMPARISON OF MICE INHERENTLY RESISTANT OR SUSCEPTIBLE TO BACILLUS ENTERITIDIS INFECTION WITH RESPECT TO FERTILITY, WEIGHT, AND SUSCEPTIBILITY TO VARIOUS ROUTES AND TYPES OF INFECTION.

Authors:  L T Webster
Journal:  J Exp Med       Date:  1933-04-30       Impact factor: 14.307

4.  EXPERIMENTAL PRODUCTION OF PNEUMOCOCCUS PNEUMONIA IN MICE BY THE INHALATION METHOD.

Authors:  E G Stillman; A Branch
Journal:  J Exp Med       Date:  1924-11-30       Impact factor: 14.307

5.  PATHOLOGY OF EXPERIMENTAL PNEUMOCOCCUS PNEUMONIA IN MICE.

Authors:  A Branch; E G Stillman
Journal:  J Exp Med       Date:  1924-11-30       Impact factor: 14.307

  5 in total
  5 in total

1.  Role of genetic resistance in invasive pneumococcal infection: identification and study of susceptibility and resistance in inbred mouse strains.

Authors:  N A Gingles; J E Alexander; A Kadioglu; P W Andrew; A Kerr; T J Mitchell; E Hopes; P Denny; S Brown; H B Jones; S Little; G C Booth; W L McPheat
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

2.  Polyamine transporter in Streptococcus pneumoniae is essential for evading early innate immune responses in pneumococcal pneumonia.

Authors:  Aswathy N Rai; Justin A Thornton; John Stokes; Imran Sunesara; Edwin Swiatlo; Bindu Nanduri
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

3.  PATHOGENESIS OF PNEUMOCOCCUS INFECTIONS IN MICE.

Authors:  G Rake
Journal:  J Exp Med       Date:  1936-01-31       Impact factor: 14.307

4.  THE RAPID INVASION OF THE BODY THROUGH THE OLFACTORY MUCOSA.

Authors:  G Rake
Journal:  J Exp Med       Date:  1937-01-31       Impact factor: 14.307

5.  INHERITANCE OF RESISTANCE OF MICE TO ENTERIC BACTERIAL AND NEUROTROPIC VIRUS INFECTIONS.

Authors:  L T Webster
Journal:  J Exp Med       Date:  1937-01-31       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.